key: cord-0993477-mwtifswp authors: Murray, Christopher JL title: Towards good practice for health statistics: lessons from the Millennium Development Goal health indicators date: 2007-03-09 journal: Lancet DOI: 10.1016/s0140-6736(07)60415-2 sha: 55a09d0431a0a229503564966c187411cc01025d doc_id: 993477 cord_uid: mwtifswp Health statistics are at the centre of an increasing number of worldwide health controversies. Several factors are sharpening the tension between the supply and demand for high quality health information, and the health-related Millennium Development Goals (MDGs) provide a high-profile example. With thousands of indicators recommended but few measured well, the worldwide health community needs to focus its efforts on improving measurement of a small set of priority areas. Priority indicators should be selected on the basis of public-health significance and several dimensions of measurability. Health statistics can be divided into three types: crude, corrected, and predicted. Health statistics are necessary inputs to planning and strategic decision making, programme implementation, monitoring progress towards targets, and assessment of what works and what does not. Crude statistics that are biased have no role in any of these steps; corrected statistics are preferred. For strategic decision making, when corrected statistics are unavailable, predicted statistics can play an important part. For monitoring progress towards agreed targets and assessment of what works and what does not, however, predicted statistics should not be used. Perhaps the most effective method to decrease controversy over health statistics and to encourage better primary data collection and the development of better analytical methods is a strong commitment to provision of an explicit data audit trail. This initiative would make available the primary data, all post-data collection adjustments, models including covariates used for farcasting and forecasting, and necessary documentation to the public. Health statistics, often viewed as a dry, dull necessity, are at the centre of several worldwide health controversies. Five factors are fuelling the tension between the supply and demand for high quality health information. First, the need for greater accountability and transparency from governments and international agencies is increasing the demand. Civil society groups, the donor community, scientists, and the public want to benchmark progress and performance of public health and medicine. An important example of this tendency is the emphasis on monitoring, including the health-related Millennium Development Goals (MDGs) 1,2 and the creation of the Healthcare Commission in the UK to independently monitor the National Health Service (NHS). 3 Second, the media, civil society, and the general public are more sceptical about both statistical and scientifi c claims. 4 An example is the public dismay about the confusing messages on fat in the diet over the past two decades. 5 Evidence of government manipulation of data during the severe acute respiratory syndrome (SARS) epidemic added to the decline in trust. 6 Third, many representatives of the technical and scientifi c community and the general public are becoming increasingly sophisticated consumers of information. The scope of relevant information is expanding from simple descriptive epidemiology about health to dimensions of public health and medicine such as quality, effi ciency, and equity. Consumers often need more detail including quantifi cation of uncertainty. Increased communication and access to diff erent views through the internet are driving scepticism and sophistication, which in turn adds to the broad demand for transparency and accountability. Fourth, as outlined in the fi rst paper in this series, 7 leaders of various global-health programmes including WHO, many public-private global health initiatives such as the Global Fund to fi ght AIDS, Tuberculosis, and Malaria, and other development agencies, feel the imperative to produce more information on their programmes and the outcomes of their investments for public consumption. Yearly reports, websites, and other publications are regarded as necessary for sustaining political and fi nancial support for their programmes, and for maintaining political priority with governments in developing countries. One result of this response has been an explosion of proposed indicators that should be measured. For example, the Drug Action Programme at WHO has 98 indicators for monitoring structure, process, and outcome 8 and the HIV department has 35 indicators. 9, 10 An internal review presented to the WHO Director General in 2002 found that WHO recommended 3500 indicators covering all programme areas of the organisation. For most of these indicators, no measurement strategy has been proposed and no measurements have been produced. Fifth, as demand for health information grows, primary data collection platforms in most developing countries are not rapidly improving. 7 However, the information technology revolution has not yet had a major eff ect on platforms for primary data collection in health systems in most developing countries. 11 In this paper, I explore good practice for health statistics from a worldwide and national perspective. Although there are many dimensions to improvement of health statistics, I concentrate on three issues that are central to fostering good practice in the use of health statistics: focusing on priority indicators; correct use of crude, corrected, or predicted statistics; and the need for explicit data audit trails. Taken together, addressing these issues would catalyse better worldwide health statistics practice and stimulate increased national interest in strengthening fundamental data platforms. I believe that increased focus on the production, analysis, and dissemination of priority health indicators will create demand for valid, reliable, and comparable health information, which will stimulate national eff orts to strengthen platforms for primary data collection. I do not discuss in detail the interventions that might be necessary to strengthen such platforms. The MDG health-related indicators are used throughout the paper to draw attention to the diffi culties with present indicators in terms of conceptualisation, implementation, and measurement. Although the MDG health-related indicators have been developed for high-level policy use, they represent the issues that generally apply to priority health indicators. Technical terms used in this paper are explained in the panel. With thousands of indicators recommended but few measured well, the worldwide health community needs to focus its eff orts on improving measurement of a small set of priority areas. Prioritisation of indicators is important for two reasons. The fi rst is cost. Human resources in the measurement fi eld are extremely scarce, both nationally and internationally. The second is visibility. Indicators drive policy attention and resources nationally and locally. This inevitable dynamic means that health problems with priority indicators will receive more attention than those that are not measured or not measured as well. Prioritisation requires several questions to be answered. Indicators can be classifi ed into six categories on the basis of what it is they measure: health outcomes, risk factors, intervention coverage, structure, process, and non-health-related results. All these types of indicators have important uses in diff erent contexts. Part of the challenge in assessment of indicators is to understand at what level they will be used. At the highest level, such as the MDG indicators, the audience is extremely broad including the technical community, governments, and the general public. Public-health importance is probably greatest for indicators of health outcomes, intervention coverage, and perhaps risk factors. Many health outcomes are of public-health importance, but because health problems are changing with new challenges, such as the epidemic of non-communicable diseases in developing countries and emergence of pandemic infl uenza, assessment of public-health signifi cance must be regularly revisited. Coverage of interventions is also important because only through the delivery of eff ective interventions to those in need can health outcomes be improved. Finally, risk factors, such as tobacco consumption, can be so strongly linked to health outcomes that they are eff ectively measures of future health outcomes in Validity refers to the extent to which a measurement is capturing what it is intended to measure. There are diff erent types of validity such as face validity, content validity, criterion validity (denoting predictive validity and concurrent validity), and construct validity (denoting convergent and discriminant validity). Reliability refers to the repeatability or consistency of a set of measurements or measuring instrument; for example, testretest reliability where a test and a retest are compared. Measurements are comparable if the same value means the same thing in the settings being compared. Two thermometers, one in Farenheit and one in Celsius, can both be valid and reliable but they do not give comparable results. Prediction about ranges of values that are not in the investigator's sample (ie, that the investigator's data set does not cover). Prediction about individuals, populations, etc, in time outside the time range of the investigator's sample. Forecasting is the process of estimation in unknown situations. Predicting is a more general term and connotes estimating for any time series, cross-sectional, or longitudinal data. Forecasting is commonly used when discussing time series data. Farcasting is trying to predict the value of a variable in a place that may be far away but is not a future value. The prior is a refl ection of some information the investigator has before the observations in the data set (the investigator should state explicitly how the information on the prior was obtained). The prior is the sum of what is known about the relationship under study. attending antenatal care in clinics in capital city", could be an important measure for the local HIV programme in the capital city, but this indicator is a poor measure of the real quantity of interest in the MDG framework-ie, national prevalence. Use of partial or proxy measures runs the danger that they slowly become the de facto quantity of interest in policy debates, distracting attention from the original objective of a policy or programme. Even when an indirect or proxy measure is the only option, mapping from the units of that measure into units of the quantity of interest is preferable-eg, ratios of children surviving to children ever born mapped into child mortality. For intervention coverage indicators, the ideal is to measure the proportion of potential health gain that is delivered for a specifi c health problem. 13 The target for MDG4 is to reduce child mortality; the ideal intervention coverage would measure the proportion of child mortality reduction that could be achieved through the whole collection of aff ordable interventions that are delivered. Compared with this standard, measurement of only one intervention, measles immunisation in the MDGs, is capturing less than 5% of what can be delivered. If only one intervention is to be measured, preference should be given to the intervention that would have the biggest eff ect on the outcome if delivered. Because intervention coverage indicators have the potential to drive managerial attention and resource allocation, claims that part indicators such as measles immunisation are good proxies for the rest of child survival interventions are unproven. The potential for indicator-driven policy also argues for the use of composites capturing the coverage of a set of interventions targeting a health problem. There should be a monotonic relation between the value of the indicator and what is desired (all other things being equal). The child death rate is a monotonic indicator; lower rates are always better than are higher ones. However, the caesarean section rate is not a monotonic indicator. Too low and too high rates are equally bad, and there is no consensus on the optimum rate. An indicator should not be a priority unless a measurement strategy that will produce valid, reliable, timely, and comparable measurements has been developed. This tenet does not mean that a measurement strategy has been implemented, otherwise, we would be trapped measuring only what has already been measured. Rather, it means that a plan has been developed. Although validity and reliability are familiar notions, comparability and timeliness have often not received adequate attention in the development of measurement strategies. Comparability is crucial-why measure an indicator over time and across countries if the measurements cannot be compared? Murray and colleagues 14 emphasise the diff erence between validity and comparability by noting that two thermometers, one in Celsius and one in Fahrenheit, can both be valid and reliable but 26 degrees on each is not comparable. Unfortunately only nine of the 16 high-importance MDG indicators have a reasonably well developed measurement strategy that will yield valid, reliable, and comparable measurements. Table 1 also emphasises that data availability overall for these health-related indicators is extremely poor, ranging from 0% for access to essential drugs to 100% for tuberculosis rate, although tuberculosis rate is almost entirely predicted from a model. For the health-related MDG indicators, overall availability of any type of statistics is 15% for 1990-2005. The 15% fi gure refers only to developing countries for all of the health-related MDG indicators. Full analysis of existing data sources in countries would probably expand this availability, but existing data are often not fully used within countries or for worldwide comparative studies. Gwatkin 15 has argued that average levels for an indicator can mask widening inequalities. To measure inequalities over time, disaggregation is necessary. Ideally, the total inequality of a health indicator across the population could be measured. 16 Total inequality can be thought of as between-group inequality plus within-group inequality. 17 For many indicators, however, only between-group inequality can be readily measured. The choice of groups for indicator disaggregation, such as rich and poor, urban and rural, occupation, race, or ethnic origin could profoundly change the comparisons of inequality across populations or over time. The disaggregation of an indicator that is proposed for monitoring inequalities should accord with evidence that this disaggregation captures the largest fraction of variance in the indicator across the populations being analysed. Boerma and colleagues 7 have discussed the platform for primary data collection that provides the basis for all health statistics: essential registration systems, sample or sentinel registration systems, household surveys, censuses, budgets, and data collected by health-service providers. Primary data collection is only the fi rst step in the generation of valid, reliable, and comparable statistics. The subsequent steps such as correcting for known biases or predicting out of sample or out of time can generate many diff erent measurements. Health statistics can be divided into three types: crude, corrected, and predicted. Crude health statistics are the measurements of indicators that come directly from primary data collection with no adjustments or corrections. These fi gures are subject to many drawbacks, including incomplete ascertainment, non-representativeness, instrument bias, misclassifi cation, and distortion. Incomplete ascertainment or incomplete coverage is a crucial diffi culty for vital registration systems and data from health-service providers. 18 Poor people and other disadvantaged groups often have the greatest health problems and do not get captured in these systems. For household surveys or other sampled data, non-representativeness can be a profound diffi culty. For example, monitoring of HIV seroprevalence in antenatal clinics is often undertaken in clinics with known high prevalence. 19 For many measurements and self-reported items on surveys, the instrument itself can be biased-eg, self-reported weights are systematically under-reported by women. 20 Where events need to be classifi ed into categories such as deaths according to the international classifi cation of diseases and injuries, misclassifi cation or inconsistent classifi cation is a common drawback. [21] [22] [23] Finally, where the stakes are high, producers of data might intentionally, or be encouraged to, distort data. Despite their restrictions, crude health statistics are proposed and used for monitoring. Figure 1 shows the MDG indicator malaria prevalence (notifi ed cases per 100 000) plotted against the prevalence of malaria parasites in blood as systematically reviewed by the MARA (Mapping Malaria Risk in Africa) project for sub-Saharan Africa. 24 Although the prevalence of clinical cases of malaria would not necessarily be perfectly correlated with parasitaemia, the absence of any relation even on log scale suggests that because of variations in ascertainment this MDG indicator cannot be used for any interpretation. In some cases, such as complete vital registration systems, crude statistics can be unbiased and appropriate for analytical use. Since bias in crude statistics is expected, the burden of proof should be to show that crude data are in fact unbiased before they are used for comparative purposes. Corrected health statistics are measurements of indicators for which two types of analytical eff ort might have been undertaken: mapping to the quantity of interest and correction for a range of known biases. Mapping into the quantity of interest includes all the measurements where the primary data collected are on an indirect result of the event under study. For example, census or survey data on the responses of mothers regarding the number of children they have ever borne and the number that are alive are used in many countries to calculate mortality in children younger than 5 years. This mapping is based on certain assumptions and models; 25,26 mapping into the quantity of interest introduces uncertainty because of parameter uncertainty, residual unexplained variance, and model choice. Correction for known bias ranges from routine procedures such as use of sample weights in household survey analysis to more complex procedures that could include analytical models. Demographers use methods 27 to estimate the incompleteness of vital registration data and then apply these to obtain corrected mortality rates. Less formal or structured methods are routinely used to correct HIV seroprevalence data in antenatal clinics to generate national estimates to address non-representativeness. 28 Correction for known bias is very important if valid, reliable, and comparable health statistics are to be generated; however, substantial scope for legitimate disagreement between analysts can be introduced. Often the details of eff orts to correct for known bias are not in the public domain, which has stifl ed open debate on the best approaches to do such corrections. Corrections for known bias could in fact introduce more error into health statistics; therefore, open debate should be encouraged. The most technical approach to correcting for known bias is to systematically review and use all available primary data and attempt to reconcile diff erences between data sources. [29] [30] [31] Systematic review and data reconciliation should not be confused with more qualitative triangulation. 32 Figure 2 provides another example of this approach by summarising all the available data on child mortality in Ghana and the corrected fi gures based on these data. 27, 33 An additional example of this approach is the work to develop internally consistent fi gures for incidence, prevalence, and death in the global burden of disease project. 34, 35 Software such as DISMOD II is used to identify inconsistencies between diff erent data sources, which the analyst must then reconcile. The advantage of systematic reviews and data reconciliation is that all relevant information is used to correct for known bias. The disadvantage is that they can require substantially more analytical work. Predicted statistics are based on a model relating the quantity of interest to covariates. Two types of predicted statistics are widely used. The fi rst is forecasting, whereby a relation is established during a period of observation and then used to predict out of time into the future. A common use of forecasting is to update corrected statistics to a more recent period to produce series of comparable statistics for a base year, such as the MDG indicator data on maternal mortality ratio in 2000, or many statistics in the MDG database for indoor air pollution, water supply, or tuberculosis prevalence. Predictions are also frequently used to generate fi gures in settings where no primary data and thus no corrected statistics are available. Since the methods are identical to those for forecasting, prediction out of sample but in the same time period has been termed farcasting. An example of farcasting is MDG estimates of solid fuel use that have been based for many countries on models relating solid fuel use to GDP per capita in those countries with data. Predicted statistics have uncertainty resulting from model choice and parameter and unexplained variance in the model. Figure 3 provides trends for maternal mortality from 1990 to 2000 for Afghanistan, Angola, Pakistan, Nigeria, South Africa, Burundi, and Algeria. These trends are not based on any empirical measurements and are strictly from predictive models. Nevertheless, the trends are diff erent and show striking fl uctuations. In Pakistan, the maternal mortality ratio is predicted to be increasing, although in Nigeria the ratio is predicted to be declining. Since these trends are not based on any real fi ndings, to infer diff erent amounts of progress on this MDG target would be completely without basis. The MDG database does not provide uncertainty for the trends in this indicator or other predicted indicators. There is a grey zone where the corrections to primary data are substantial enough that they can become diffi cult to distinguish from predicted statistics. In a Bayesian context, predictions provide priors and the primary data with correction allow these priors to be updated. There are, however, cases where the recorded data give little information beyond the prior. Health statistics are necessary inputs to planning and strategic decision making, programme implementation, monitoring progress towards targets, and assessment of what works and what does not. Crude statistics that are biased have no role in any of these steps. They are, however, an important input to research and are the basis for corrected statistics with greater validity, reliability, and comparability. There is no cogent reason why crude statistics with known biases should be used when corrected statistics are available or can be developed. Nevertheless, several agencies report crude statistics. For example, the US Centers for Disease Control and Prevention report on levels of obesity by state with self-reported weights and heights in the behavioural risk factor surveillance system survey, which are known to underestimate obesity by roughly 50%. 20 By reporting crude statistics, the onus for correction of known bias to allow for interpretation is shifted to the user. Although this approach makes the task easier for the data generator, it is predicated on a strange premise: the users, including policymakers and the concerned public, are in a better position to adjust for known bias than is the health statistician. In fact, the failure to correct for known bias underlies some of the most egregious examples of health statistics. Publication of government data in WHO's communicable disease global atlas 36 on notifi ed cases and deaths for rabies, cholera, sexually transmitted infections, and malaria are notable examples of the promotion of crude statistics. WHO claims that the atlas "is bringing together for analysis and comparison standardized data and statistics for infectious diseases at country, regional, and global levels". 36 The style of presentation with maps encourages cross-country comparisons, but simple inspection shows that because of ascertainment bias, misclassifi cation, and non-representativeness, the numbers are not valid, reliable, or comparable-eg, those for rabies for Iran and Pakistan diff er by two orders of magnitude. Political arguments, such as the importance of respecting national sovereignty, are often given to explain the use of crude fi gures. But political pedigree is not a legitimate argument to favour one statistic over another. Frequently governments do have the best primary data and corrected statistics, but the preference for data from the government must be based on the merits of the data, not the politics. The importance of distinguishing political pedigree from substantive arguments about the reliability, validity, and comparability of health statistics is just as true nationally, when geographic subunits are being compared, as it is worldwide. For forward-looking decision making, advocacy for funds, planning, strategic decisions, research, and development investments, people who make decisions need the best available information. We cannot argue that we should allocate no resources to an area of need because good primary data and corrected statistics are not available. For these decisions, when corrected statistics are not available, predicted statistics can play an important part. The publication of the world population prospects every 2 years by the UN Population Division 37 is a good example of the use of predicted statistics. This publication provides population, mortality, and fertility statistics for all countries from 1950 to 2050. For some countries, much of the trend from 1950 up to now is based on corrected statistics, but for many countries much or all of the sequence is based on predictions. Because the world population prospects is revised every 2 years, the entire set of fi gures from 1950 to 2050 is revised when new data become available. Even though much of the sequence is based on predictions, these basic demo graphic fi gures are crucial for various planning and strategic decisions. For monitoring progress towards agreed targets and assessment of what is eff ective and what is not, the case for using predicted statistics is unconvincing. Nationally or locally, the reason for monitoring is to fi nd out whether present policies and programmes are leading us in the right direction or to identify when unexpected factors are changing trends. If data for monitoring are predicted and the prediction model explains much of the observed variance, the predicted statistics can correctly identify the true trend in many cases. However, the prediction is not sensitive to the actual policies and programmes that have been pursued. That statistics used for monitoring have zero probability of detecting an unexpected trend does not seem right. Imagine enrolling your child in a school, which then hands you the results of your child's examination scores for the end of the year on the fi rst day of attendance. These results have been forecast by a very good model and might be right most of the time. However, the grades or assessment are not aff ected in any way by what your child does during the year. A test for the use of statistics for monitoring and assessment should be that the statistics in question have a reasonable probability of detecting real changes in the quantity of interest. This concern is great when we intend to assess what works and what does not; here predicted statistics should have no role. Because predicted statistics have a zero probability of detecting changes from an abrupt adjustment in policy, they should not be used for this type of monitoring and assessment. Predicted statistics, however, have been substantially used in monitoring. For example, 20 of the health-related MDG indicators in table 1 use some predicted statistics. The World Health Report in 2000 for health system performance used predicted statistics extensively. 38 Two types of argument have been made to support the use of predicted statistics for monitoring. First, several countries in greatest need will have little or no data to report, and if no statistics are reported the topic will lose policy attention. Second, worldwide advocacy needs information on global monitoring. Although the use of predicted statistics to bring attention to a diffi culty seems warranted both nationally and internationally, the temptation to use such information once produced for actual monitoring and even assessment is very great. I believe that if predicted statistics are to be used in such cases, the user must make it very clear that predicted statistics are being used and this use should not become a routine activity. Therefore, publication of databases of annual predicted fi gures, such as for some MDG indicators, does not seem justifi ed. Reported indicator series should, at an absolute minimum, indicate whether fi gures are based on crude, corrected, or predicted values. Regional or worldwide aggregates are often based on mixtures of crude, corrected, and predicted data, and the relative proportion of the component national fi gure based on these three types should be shown to the user. Perhaps the most eff ective method by which to decrease controversy over health statistics and to encourage better primary data collection and development of better analytical methods is a strong commitment to provision of an explicit data audit trail. This method would make primary data, all post-data collection adjustments, models including covariates used for farcasting and forecasting, and necessary documentation available to the public. An explicit data audit trail would allow health statistics to be subject to the scientifi c principle of replication. A sceptical user should be able to reproduce every fi gure including all steps along the way. Decision makers, the media, or the public are unlikely to use the explicit data audit trail, but the requirement to publish this trail will over time lead to improved practice. The expectation that peers in the technical community will be able to critique methods, suggest other data sources, and even generate alternative fi gures will provide a powerful incentive for improved measurement. Few in the international community are opposed to the idea of an explicit data audit trail. There are three diffi culties, however, that have restricted the adoption of this approach. First, documentation of all adjustments for known bias and the use of farcasting and forecasting models is time-consuming and expensive. Second, transparency about how some estimates are generated can increase debate about the validity of fi gures in the short term, which is a concern for some programme managers. Third, the component of the explicit data audit trail that calls for primary data to be accessible to the public or at least to interested analysts might confl ict with national privacy laws governing data collection, which is a very important issue. In some countries such as the USA, data are becoming harder to obtain. For example, the National Center for Health Statistics (NCHS) has stopped releasing mortality data for counties because of privacy concerns. Increasing concerns about privacy are in direct confl ict with another international trend towards more countries adopting freedom of information laws. In 2002, Mexico passed a sweeping freedom of information act and set up a Federal Institute for Access to Public Information about Mexico, which guarantees unprecedented access to any information held by the government. 39 In India, the Right to Information Act of 2005, seems to provide similar access to information. 40 Various other countries are pursuing similar legislation. 41, 42 Balancing privacy concerns with the need for information to be in the public domain to create a culture of transparency will be a major challenge in the coming decades. Once individual identifi ers such as names and addresses have been removed from survey, census, or vital registration data, privacy concerns revolve around the possibility that, with some investigation, individuals could be identifi ed. 43 For example, perhaps only one 84-year-old woman died in Omaha county, USA, so that the analyst could with further investigation fi nd the name of this individual and what she died of. Such a hypothetical possibility must be balanced against the damage to the community by suppression of health information that could improve population health. In the case of death data in the USA, the NCHS position is hard to understand since death certifi cates for all individuals including names are public records that can be obtained in every state. Clearly, there are important legitimate concerns about data privacy. However, in some cases arguments about data confi dentiality are used by institutions to avoid the release of data to other groups. Datasets are often viewed by researchers or organisations as private possessions. Data, of course, are a classic example of a general public good. There is a potential cost that could ultimately be counted in human health of keeping data from the public domain. The principle of an explicit data audit trail and replicability might also be preserved if mechanisms exist to allow restricted access to various datasets with stronger safeguards. Journals such as The Lancet, funding agencies, and governments all have an important part to play in transformation of the culture of data from a feudal to an open democratic model. Any eff orts that move towards an explicit data audit trail should be encouraged, including intermediate steps such as provision of detailed information on primary data sources and types of adjustments that have been undertaken. Several good practice recommendations for health indicators and their measurement follow from this discussion. These recommendations could lead over time to a more focused eff ort on production of valid, reliable, and comparable information to serve many information needs. National and worldwide eff orts to improve health statistics should focus on a smaller set of priority indicators rather than the thousands that are currently recommended. Priority health indicators should be selected on the basis of public-health importance and the existence of a pragmatic measurement strategy. I believe that focusing attention within and across countries on a restricted set of priority indicators will help show how measurement can foster health improvement. Analyses based on these priority indicators can foster demand from decision makers, the media, civil society, the technical community, and the public for better health measurement. Eff orts to strengthen platforms for primary data collection driven by this demand are more likely to gain broad support than are calls for strengthening these platforms that are not linked to specifi c analytical uses. The measurement strategy should be designed to produce valid, reliable, and comparable information. If the results of measurement are not comparable over time and across places, they will not be useful for monitoring or assessment. Comparability has not been given suffi cient attention in the development of measurement strategies. Furthermore, every eff ort should be made to produce statistics for the true quantity of interest instead of proxies. Proxy indicators should be mapped into the quantity of interest and the uncertainty in that mapping quantifi ed. Crude statistics from primary data collection platforms should be reported as a resource for the analysis and research community, but should be clearly distinguished from corrected statistics for interpretive purposes. The most detailed information possible, including metadata and wherever possible microdata, should be in the public domain. Statistics used for monitoring and assessment should always be corrected for known biases, and the basis for these corrections should be in the public domain. Predicted statistics should in general not be used for actual monitoring of national or local progress, and should never be used for assessing what works and what does not. Predicted statistics have an important and useful role in helping to inform planning, strategic decision making, and research and development prioritisation when corrected statistics are unavailable. Whenever predicted statistics are used, however, eff orts should be made to adequately characterise the uncertainty in the predictions from all sources so that they are interpreted with caution. All statistics produced for all purposes should have a well documented, explicit data audit trail, which allows a sceptical scientist to entirely replicate the generation of the corrected or predicted statistics. Due attention should be given to protection of public interest in transparency and accountability that derives from having data in the public domain. The MDG health-related indicators have been used to draw attention to many of the points in this paper. Overall, the set of indicators, the measurement strategies, and the implementation of the MDG health-related indicators is very poor. At least half the indicators are not of high enough public-health importance to warrant major international attention or investments in their assessment. Data availability for developing countries overall is 15%, and even in 2000 when a special eff ort was made, it reached 44%. Most of these fi gures are predicted statistics that do not provide a reasonable basis for monitoring progress. The dilemma is that data systems and measurements are so weak that only undernutrition, child mortality, measles immunisation, and attended deliveries have eff ective measurement strategies in place. WHO, UNICEF, UNAIDS, and other agencies responsible for monitoring the MDGs rely on using predicted statistics for most other indicators so that attention on the MDGs does not fade. Predicted statistics are a reasonable approach for identifi cation of diffi culties and for stimulation of policy interest. However, the worldwide community is failing in implementation of viable measurement strategies for real monitoring. Global Monitoring Report 2004: policies and actions for achieving the Millennium Development Goals and related outcomes. Washington: The International Bank for Reconstruction and Development/The World Bank London: Healthcare Commission WHO misses AIDS-treatment goal More questions than answers: recent results from a major study have challenged many assumptions about women's health. A look at how the trials got started and what to expect next China pledges transparency over bird fl u. Guardian Unlimited Health statistics now: are we making the right investments? Indicators for monitoring national drug policies. Geneva: World Health Organization National AIDS programmes: a guide to indicators for monitoring and evaluating national antiretroviral programmes. Geneva: World Health Organization World Bank/Measure DHS/Family Health International. National AIDS programmes: a guide to indicators for monitoring and evaluating national HIV/AIDS prevention programmes for young people Millennium indicators database Access, utilization, quality, and eff ective coverage: an integrated conceptual framework and measurement strategy Health systems performance assessment: debates, methods and empiricism How much would poor people gain from faster progress towards the Millennium Development Goals for health? Defi ning and measuring health inequality: an approach based on the distribution of health expectancy Measuring total health inequality: adding individual variation to group-level diff erences Health systems performance assessment: debates, methods and empiricism Estimating the global burden of HIV/AIDS: what do we really know about the HIV pandemic? Trends in national and state-level obesity in the USA after correction for self-report bias: analysis of health surveys Understanding the coronary heart disease versus total cardiovascular mortality paradox: a method to enhance the comparability of cardiovascular death statistics in the United States Accuracy of death certifi cates for coding coronary heart disease as the cause of death Accuracy of death certifi cation in an autopsied population with specifi c attention to malignant neoplasms and vascular diseases Mapping Malaria Risk in Africa (MARA). MARA-LITe database United Nations Population Division. QFIVE: microcomputer program for child mortality estimation United Nations Population Division. Manual X: indirect demographic estimation Unconventional approaches to mortality estimation Report of a meeting of the UNAIDS/WHO reference group for "Estimates, Modelling and Projections WHO Child Health Epidemiology Reference Group. WHO estimates of the causes of death in children Estimating the causes of 4 million neonatal deaths in the year 2000 The burden of malaria mortality among African children in the year 2000 Methodological triangulation in public health research-advancement or mirage The global burden of disease: a comprehensive assessment of mortality and disability from diseases, injuries, and risk factors in 1990 and projected to 2020 University Press on behalf of the World Health Organization and the World Bank Quantifying global mortality, disability, and the contribution of risk factors: results of the Global Burden of Disease Study Geneva: World Health Organization World population prospects. The 2004 revision The world health report 2000-health systems: improving performance. Geneva: World Health Organization The FederalInstitute for Access to Public Information in Mexico and a Culture of Transparency. Project for Global Communication Studies, Annenberg School for Communication,University of Pennsylvania. A Report for the William and Flora Hewlett Foundation Indians win right to information Alliance 72 submits its recommendations on the "Transparency Law" to Congress. International Freedom of Expression eXchange Pakistan: changes to freedom of information law sought. Centre for Peace and Development Initiative calls for lesser fees to request information Protecting data privacy in health services research I was former Executive Director of the Evidence and Information for Policy Cluster at the World Health Organisation. I have no confl icts of interest that may have infl uenced this work or the conclusions of the manuscript.